Allergan, Inc. News Headlines

AGN 
$165.515
*  
6.655
3.87%
Get AGN Alerts
*Delayed - data as of Jul. 31, 2014 14:58 ET  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

McKesson Beats on Q1 Earnings & Revenues, Increases Guidance - Analyst Blog
7/31/2014 1:05:00 PM - Zacks.com

Update: Looks Like Bill Ackman Does Not Have Enough Allergan Shareholder Votes
7/31/2014 11:29:00 AM - Seeking Alpha

Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog
7/31/2014 10:41:00 AM - Zacks.com

U.S. Hot Stocks: Hot Stocks to Watch
7/31/2014 9:34:00 AM - Dow Jones Business News

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog
7/29/2014 12:30:00 PM - Zacks.com

Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures - Analyst Blog
7/29/2014 10:38:00 AM - Zacks.com

Novartis Division Gets European Approval for Simbrinza - Analyst Blog
7/28/2014 6:30:00 PM - Zacks.com

Celgene Beats Q2 Earnings Estimates on Strong Revlimid Sales - Analyst Blog
7/25/2014 3:45:00 PM - Zacks.com

Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog
7/25/2014 2:45:00 PM - Zacks.com

Roche's 1H14 Earnings & Revenues Up Y/Y, Outlook Reaffirmed - Analyst Blog
7/25/2014 12:30:00 PM - Zacks.com

AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus - Analyst Blog
7/25/2014 11:52:00 AM - Zacks.com

Allergan's OZURDEX Gets European Positive Opinion For Treating DME
7/25/2014 8:09:00 AM - RTT News

Shire, ArmaGen Ink Licensing Agreeement for AGT-182 - Analyst Blog
7/24/2014 6:00:00 PM - Zacks.com

Bristol-Myers (BMY) Beats on Q2 Earnings, Maintains Outlook - Analyst Blog
7/24/2014 5:00:00 PM - Zacks.com

Eli Lilly Beats on Q2 Earnings & Revs, Maintains View - Analyst Blog
7/24/2014 9:05:00 AM - Zacks.com

Concord Medical Services Holdings (CCM) Soars: Stock Adds 10.7% in Session - Tale of the Tape
7/24/2014 8:57:00 AM - Zacks.com

Ominous Signs For Valeant In The Allergan Q2 Earnings Call
7/23/2014 3:02:00 PM - Seeking Alpha

Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog
7/23/2014 1:41:00 PM - Zacks.com

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
7/23/2014 9:30:00 AM - Zacks.com

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
7/22/2014 5:20:00 PM - Zacks.com

Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts - Analyst Blog
7/22/2014 4:30:00 PM - Zacks.com

Company News for July 22, 2014 - Corporate Summary
7/22/2014 10:10:00 AM - Zacks.com

Cramer's Mad Money - Go For GoPro (7/21/14)
7/22/2014 6:39:00 AM - Seeking Alpha

TSX Ends Lower On Global Cues -- Canadian Commentary
7/21/2014 5:22:00 PM - RTT News

Sector Update: Healthcare Stocks Ending Lower Today; Allergan Investors Adding to Stakes as Buyout Talk Heats Up
7/21/2014 4:02:46 PM - MT Newswires